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Hailey–Hailey disease (HHD) is a rare autosomal dominant disorder characterized by recurrent skin lesions pre-
dominantly involving the body folds. It is caused by heterozygous mutations in the ATP2C1 gene, encoding the
human secretory pathway Ca2þ /Mn2þ -ATPase protein 1 (hSPCA1). In this report we describe the molecular studies
performed in eight HHD cases from Italy that led us to identify six different mutations scattered through the ATP2C1
gene in seven of eight cases. Four of the detected mutations were novel. Our results conﬁrm the high allelic
heterogeneity of the ATP2C1 gene and support the notion that HHD is a genetically homogeneous disorder. Fur-
thermore, we created a table summarizing all previously reported ATP2C1 mutations, adapting the nomenclature, if
needed, according to the guidelines of the Human Genome Variation Society.
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Hailey–Hailey disease (HHD), or familial benign chronic
pemphigus (MIM 169600), is an autosomal dominant inher-
ited disorder of keratinocyte cohesion first described by the
Hailey dermatologist brothers (Hailey and Hailey, 1939). It
is characterized by suprabasal cell separation (acantholysis)
of the epidermis resulting in recurrent blisters, crusted ero-
sions, and warty papules that occur mainly on the neck,
axillae, groin, and other intertrigenous folds. Lesions rarely
involve mucosal surfaces and they usually first appear after
puberty, mostly in the third or fourth decade (Burge, 1992).
The defective gene in HHD, designated as ATP2C1, was
identified by two independent groups (Hu et al, 2000; Sud-
brak et al, 2000). So far, no evidence of genetic hetero-
geneity has been found. ATP2C1 encodes the human
secretory pathway Ca2þ /Mn2þ -ATPase protein 1
(hSPCA1), localized in the Golgi apparatus (Behne et al,
2003). This protein serves to actively pump Ca2þ and Mn2þ
across Golgi membranes, thus contributing to the control of
these cations’ intracellular homeostasis (Missiaen et al,
2004). A large number of pathological variants scattered
throughout the ATP2C1 gene are described nowadays (Hu
et al, 2000; Sudbrak et al, 2000; Ikeda et al, 2001; Chao
et al, 2002; Dobson-Stone et al, 2002; Yokota et al, 2002; Li
et al, 2003; Fairclough et al, 2004; Poblete-Gutierrez et al,
2004), the majority of which are non-sense, frameshift, and
splice-site mutations. These mutations are summarized in
Table S1. It is thus thought that haploinsufficiency of
hSPCA1 is the more likely mechanism underlying the
dominant inheritance of HHD (Ikeda et al, 2001; Fairclough
et al, 2003, 2004; Ton and Rao, 2004). No single mutation
appears to be related to a substantial number of HHD cases
in all the screened populations. To provide further contri-
bution to our understanding of the molecular basis of HHD,
we performed mutation analysis of the ATP2C1 gene in eight
HHD familial or sporadic cases belonging to the Italian pop-
ulation. We identified in seven of the studied cases six
different ATP2C1 mutations, four of which were novel.
Results
Sequencing of ATP2C1 entire coding region and exon–intron
boundaries revealed the presence of a heterozygous muta-
tion in seven of the eight investigated familial or sporadic
cases (Table S1 and Table I). Four of these mutations
(c.360þ1G4A, c.1869delG, c.2422_2423delAC, c.2264delA)
have not been previously reported and were not found in 50
Italian control subjects without HHD. One of the detected
ATP2C1 variants (c.2422_2423delAC) was shared between
two unrelated cases. Microsatellite analysis evidenced, in
these two patients, a different haplotype in the region sur-
rounding the ATP2C1 gene, excluding the founder origin of the
mutation. The sporadic case in which no mutation was found
(SHHD-4) showed an HHD typical phenotype. In this patient
microsatellite genotyping excluded the presence of a large
deletion.
Discussion
In this study we screened DNA in patients with HHD be-
longing to the Italian population for mutations in ATP2C1.
Abbreviations: HHD, Hailey–Hailey disease; hSPCA1, human se-
cretory pathway Ca2þ /Mn2þ -ATPase protein 1; PTC, premature
termination codon
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We found six different ATP2C1 variants in seven of eight
investigated cases. Four of the detected variants were not
previously reported and all of them, excluded from a panel
of healthy population-matched controls, are likely to cause
the disease. Three of these novel variants (c.1869delG,
c.2422_2423delAC, c.2264delA) are in fact predicted to re-
sult in the absence or a marked reduction of a prematurely
truncated hSPCA1 protein either via non–sense-mediated
mRNA decay (Frischmeyer and Dietz, 1999) or through
intracellular endoplasmic reticulum–mediated degradation
(Hampton, 2002). The fourth one (c.360þ1G4A) is a splic-
ing mutation occurring at the invariant guanine of intron 5
splice donor site, and is thought to alter ATP2C1 mRNA
splicing.
The novel frameshift c.2422_2423delAC mutation was
found in two sporadic unrelated cases (SHHD-1 and SHHD-
3). As the possibility of a founder effect was ruled out by
microsatellite analysis, we suggest that this variant, occur-
ring within the dinucleotide tandem repeat ‘‘acacac,’’ rep-
resents a mutational ‘‘hotspot’’ because of its susceptibility
to replication slipped strand mispairing.
We did not identify mutation in ATP2C1 in a case (SHHD-
4) with classical HHD. In this patient, in whom a large
deletion was excluded, the disease could be caused
by a variant occurring outside the studied regions or,
alternatively, by partial deletion of the ATP2C1 gene
leading to the absence of PCR amplification in one
allele.
In general, no genotype–phenotype correlations between
the nature of ATP2C1 mutation and the clinical features of
HHD were observed, in agreement with previous studies
(Ikeda et al, 2001; Chao et al, 2002). The variation of disease
characteristics that we observed in patients belonging to
the same family or in two unrelated individuals sharing the
same mutation (Table I) confirms the suggestion that HHD
phenotype is strongly influenced by genetic modifiers and/
or environmental factors (Dobson Stone et al, 2002).
In line with the results of other studies (Table S1), re-
porting only two mutations (p.Arg153X and c.2374_
2377delTTTG) recurring in more than four unrelated HHD
individuals, in the Italian population also no single ATP2C1
mutation seems to be able to account for a consistent
number of cases. In conclusion, our results confirm the high
allelic heterogeneity and the absence of clustering of
ATP2C1 gene mutations in the Italian population also, and
further support the theory of absence of locus heterogeneity
in HHD.
Materials and Methods
This study was conducted according to Declaration of Helsinki
Principles and was approved by the S. Gallicano Institute Ethical
Committee.
In total, two familial and six sporadic HHD cases were included
in the study. All the investigated subjects were of Italian origin. In
each patient diagnosis was established by a dermatologist on the
basis of clinical features, medical, and familial history. In addition, a
cutaneous biopsy performed in all sporadic cases and in at least
one member of each family showed the characteristic HHD his-
tological findings (Burge et al, 1991). Profiles of the patients/fam-
ilies are summarized in Table I. Blood samples were taken from
probands and, in some cases, from their relatives after they had
given informed consent. Genomic DNA was extracted from whole
blood using a Qiagen kit (Blood mini kit). All 28 translated ATP2C1
exons and exon–intron boundaries were amplified by using 28
couples of primers (primer sequences were kindly supplied by
Antony P. Monaco, University of Oxford) (Sudbrak et al, 2000;
Dobson-Stone et al, 2002). Amplification products were then se-
quenced in both directions using an automatic sequencing system
(310, Applied Biosystems, Foster City, CA, USA). Sequencing re-
sults were analyzed with reference to cDNA and gDNA ATP2C1
sequences (GeneBank Accession Number: NM_014382.2 and
Table I. Identiﬁed mutations and principal characteristics of the investigated subjects
Patientsa Mutationb Sex Age Age of onset
No. of involved
skin sites Precipitating factors
Presence
of lesions
(mo per y)
SHHD-1 (1) [1] c.2422_2423delAC F 59 40 3 Sweating, heat 8
SHHD-2c (1) [3] c.2264delA M 48 41 4 Sweating, sun exposure 12
SHHD-3 (1) [3] c.2422_2423delAC F 63 53 2 Sweating, sun exposure 5
SHHD-4 (1) [1] Not identified F 51 42 2 Sweating, sun exposure 9
SHHD-5 (1) [3] c.519_520insA F 47 42 1 Sweating, emotional stress 1
SHHD-6 (1) [1] c.1869delG F 32 30 5 Sweating, sun exposure 12
FHHD-1 (6) [3] c.2395C4T M 67 45 2 Sweating, heat 7
F 63 43 3 Sweating, heat 9
M 37 22 1 Sweating, heat 5
FHHD-2 (not known) [1] c.360þ1G4A M 54 42 4 Sweating, heat 4
aPrefix ‘‘S’’ before HHD indicates sporadic cases, whereas prefix ‘‘F’’ describes familial cases. Number of affected individuals in each family is
indicated in the round brackets, whereas the number of investigated subjects is reported in the square brackets.
bMutations are indicated on the basis of the DNA change.
cTwo offspring of this patient (one male and one female), aged 23 and 21, respectively, who inherited the mutation from the father, are until now disease
free.
HHD, Hailey–Hailey disease.
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NC_000003.9, respectively). Microsatellite analyses were per-
formed by PCR amplification of genomic DNA using specific prim-
ers for the polymorphic microsatellite markers D3S3514, D3S1596,
D3S1587, and D3S1292 (The GDB Human Genome Database).
PCR products length was then analyzed using the GeneGel Excel
12.5/24 kit on a GenePhor Electrophoresis Unit (Amersham Bio-
sciences, Fairfield, CT, USA). Sequence or restriction endonuc-
lease analysis of exons containing novel mutations was performed
in 50 control samples.
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